Envoy Research Development from 2010 to 2025

COCHW Stock   0.04  0.00  0.00%   
Envoy Medical Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 7.6 M in 2025. During the period from 2010 to 2025, Envoy Medical Research Development regression line of quarterly data had mean square error of 2.5 T and geometric mean of  4,623,337. View All Fundamentals
 
Research Development  
First Reported
2010-12-31
Previous Quarter
10.2 M
Current Value
7.6 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Envoy Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Envoy Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.3 K, Other Operating Expenses of 11.9 M or Total Operating Expenses of 11.2 M, as well as many indicators such as Price To Sales Ratio of 125.4 K, Dividend Yield of 1.0E-4 or Days Sales Outstanding of 1.4 K. Envoy financial statements analysis is a perfect complement when working with Envoy Medical Valuation or Volatility modules.
  
Build AI portfolio with Envoy Stock
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Latest Envoy Medical's Research Development Growth Pattern

Below is the plot of the Research Development of Envoy Medical over the last few years. It is Envoy Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Envoy Medical's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Envoy Research Development Regression Statistics

Arithmetic Mean4,906,641
Geometric Mean4,623,337
Coefficient Of Variation41.69
Mean Deviation1,500,291
Median3,939,000
Standard Deviation2,045,634
Sample Variance4.2T
Range6.2M
R-Value0.67
Mean Square Error2.5T
R-Squared0.45
Significance0
Slope288,564
Total Sum of Squares62.8T

Envoy Research Development History

20257.6 M
202410.2 M
2023M
20224.5 M

About Envoy Medical Financial Statements

Envoy Medical investors use historical fundamental indicators, such as Envoy Medical's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Envoy Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development10.2 M7.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Envoy Stock Analysis

When running Envoy Medical's price analysis, check to measure Envoy Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Envoy Medical is operating at the current time. Most of Envoy Medical's value examination focuses on studying past and present price action to predict the probability of Envoy Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Envoy Medical's price. Additionally, you may evaluate how the addition of Envoy Medical to your portfolios can decrease your overall portfolio volatility.